Inventor · disambiguated record
Marcus Schindler
Also filed as: SCHINDLER MARCUS
16 granted patents·16 pending applications·73 citations·filing 2003–2025
92Inventor score
Files withBOEHRINGER INGELHEIM INT9BOEHRINGER INGELHEIM PHARMA7SPROUT PHARMACEUTICALS INC4CECI ANGELO3Schubert Additive Solutions GmbH3
Top patents by PatentIndex Score
32 records- 0192US8785458B2Use of flibanserin in the treatment of obesityCECI ANGELO·Filed 2012·Granted Jul 22, 2014·15 cites·12 claims
- 0291US8227476B2Use of flibanserin in the treatment of obesityCECI ANGELO·Filed 2006·Granted Jul 24, 2012·14 cites·5 claims
- 0385US8067590B2Pyridone derivates with MCH antagonistic activity and medicaments comprising these compoundsSTENKAMP DIRK·Filed 2007·Granted Nov 29, 2011·9 cites·12 claims
- 0484US7538115B2Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereofBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted May 26, 2009·4 cites·14 claims
- 0582US9730927B2Use of flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·2 cites·20 claims
- 0682US7592373B2Amide compounds with MCH antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM INT·Filed 2004·Granted Sep 22, 2009·13 cites·18 claims
- 0778US7026312B2Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereofBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Apr 11, 2006·8 cites·12 claims
- 0877US10874668B2Use of Flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2019·Granted Dec 29, 2020·0 cites·20 claims
- 0977US7605176B2β-ketoamide compounds with MCH antagonistic activityBOEHRINGER INGELHEIM INT·Filed 2005·Granted Oct 20, 2009·2 cites·18 claims
- 1074US7592358B2Alkyne compounds with MCH antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Sep 22, 2009·2 cites·18 claims
- 1173US7524862B2Alkyne compounds with MCH antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM INT·Filed 2005·Granted Apr 28, 2009·1 cites·27 claims
- 1273US2021069185A1Use of flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1370US2025251714A1Method for the additive manufacturing of at least one component of defined component propertiesSchubert Additive Solutions GmbH·Filed 2025·Application pending·0 cites
- 1468US7595312B2Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Sep 29, 2009·3 cites·66 claims
- 1565US2010113411A1Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2009·Application pending·0 cites
- 1664US10335407B2Use of flibanserin in the treatment of obesitySPROUT PHARMACEUTICALS INC·Filed 2017·Granted Jul 2, 2019·0 cites·17 claims
- 1763US2015072994A1Use of Flibanserin in the Treatment of ObesityCECI ANGELO·Filed 2014·Application pending·0 cites
- 1860US7700589B2CGRP antagonistsBOEHRINGER INGELHEIM PHARMA·Filed 2007·Granted Apr 20, 2010·0 cites·6 claims
- 1959US12332629B2Method for the additive manufacturing of at least one component of defined component propertiesSchubert Additive Solutions GmbH·Filed 2020·Granted Jun 17, 2025·0 cites·19 claims
- 2054US2004132716A1CGRP antagonistsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 2153US2012165304A16,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing themMUELLER STEPHAN-GEORG·Filed 2009·Application pending·0 cites
- 2248US2010197908A1Pyridazine Derivatives with MCH Antagonistic Activity and Medicaments Comprising These CompoundsBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 2348US2010152171A1CGRP AntagonistsBOEHRINGER INGELHEIM PHARMA·Filed 2010·Application pending·0 cites
- 2445US2012010185A1New pyridone derivates with mch antagonistic activity and medicaments comprising these compoundsSTENKAMP DIRK·Filed 2011·Application pending·0 cites
- 2545US2004192729A1Carboxylic acids and the esters thereof, pharmaceutical compositions thereto and processes for the preparation thereofBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 2645US2007111981A1New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compoundsROTH GERALD J·Filed 2006·Application pending·0 cites
- 2744US2005239826A1Alkyne compounds with MCH antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 2844US2005267120A1Alkyne compounds with MCH antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 2944US2005245529A1Alkyne compounds with MCH antagonistic activity and medicaments comprising these compoundsBOEHRINGER INGELHEIM INT·Filed 2005·Application pending·0 cites
- 3043US9346816B26,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing themMUELLER STEPHAN-GEORG·Filed 2013·Granted May 24, 2016·0 cites·9 claims
- 3142US2007185128A1Compounds and compositions for treating obesityCONDE-FRIEBOES KILIAN W·Filed 2003·Application pending·0 cites
- 3242US2023333536A1Method for operating an additive manufacturing deviceSchubert Additive Solutions GmbH·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Marcus Schindler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →